scholarly journals Circulating Protein Fragments of Cartilage and Connective Tissue Degradation Are Diagnostic and Prognostic Markers of Rheumatoid Arthritis and Ankylosing Spondylitis

PLoS ONE ◽  
2013 ◽  
Vol 8 (1) ◽  
pp. e54504 ◽  
Author(s):  
Anne C. Bay-Jensen ◽  
Stephanie Wichuk ◽  
Inger Byrjalsen ◽  
Diana J. Leeming ◽  
Nathalie Morency ◽  
...  
PLoS ONE ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. e0149329 ◽  
Author(s):  
Karen I. Maijer ◽  
Natasja Stæhr Gudmann ◽  
Morten Asser Karsdal ◽  
Daniëlle M. Gerlag ◽  
Paul Peter Tak ◽  
...  

2021 ◽  
pp. 245-252
Author(s):  
David Howell

This chapter describes the anaesthetic management of the patient with those musculoskeletal disorders which are relevant to anaesthetic practice. Topics covered include rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE); systemic sclerosis; scoliosis and achondroplasia. For each topic, pre-operative investigation and optimisation, treatment, and anaesthetic management are described.


Author(s):  
Colin Berry

This chapter describes the anaesthetic management of the patient with those musculoskeletal disorders which are relevant to anaesthetic practice. Topics covered include rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, systemic sclerosis, scoliosis, and achondroplasia. For each topic, preoperative investigation and optimization, treatment, and anaesthetic management are described.


Author(s):  
Murray Longmore ◽  
Ian B. Wilkinson ◽  
Andrew Baldwin ◽  
Elizabeth Wallin

The rheumatological historyAssessing the locomotor systemRheumatological investigationsBack painOsteoarthritis (oa)Septic arthritisRheumatoid arthritis (ra)Crystal arthropathies:Goutcppd arthropathySpondyloarthritides:Ankylosing spondylitis (as)Enteropathic, psoriatic and reactive arthritisAutoimmune connective tissue diseases:Mixed connective tissue disease...


2013 ◽  
Vol 2013 ◽  
pp. 1-4
Author(s):  
Şenol Kobak ◽  
Ahmet Karaarslan ◽  
Fahrettin Oksel

Rheumatoid arthritis (RA) is considered as a connective tissue disease while ankylosing spondylitis (AS) is a prototype of spondyloarthritis. These diseases are seen concomitantly only very rarely. Also, rituximab has proven efficacy in the treatment of RA while its role in the treatment of AS is unclear. In this presentation, the concomitant presence of RA and AS in a 43-year-old male patient as well as the efficacy and safety of rituximab is discussed. Rituximab was given due to lack of response to treatment with anti-TNF-alpha. Evaluations made at the 6th and 12th months of treatment showed complete response for RA and partial response for AS.


Sign in / Sign up

Export Citation Format

Share Document